Dr. Reddy’s Laboratories has launched Toripalimab ... in India. NPC is a rare form of head and neck cancer. However, the prognosis of the disease for patients in advanced stages is poor ...
Branded Markets (India and Emerging Markets), Dr. Reddy’s, said. Nasopharyngeal carcinoma (NPC) is a rare, aggressive form of head and neck cancer that originates in the nasopharynx, the upper ...
Neutral Dr Reddys Laboratories; target of Rs 1390: Motilal Oswal Nov 06 2024 08:21 PM Hold Dr Reddyu2019s Laboratories; target of Rs 1270: ICICI Securities Nov 06 2024 01:35 PM Sell Dr Reddy's ...